OpGen
OPGN
#9255
Rank
A$0.15 B
Marketcap
A$15.05
Share price
11.11%
Change (1 day)
583.83%
Change (1 year)

Revenue for OpGen (OPGN)

Revenue in 2024 (TTM): A$8.33 Million

According to OpGen 's latest financial reports the company's current revenue (TTM ) is A$7.82 Million. an increase over the revenue in the year 2023 that were of A$5.01 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for OpGen from 2014 to 2024

Annual revenue

Year Revenue Change
2024 A$8.35 M66.5%
2023 A$5.01 M30.95%
2022 A$3.83 M-35.49%
2021 A$5.93 M8.37%
2020 A$5.48 M9.68%
2019 A$4.99 M19.48%
2018 A$4.18 M1.69%
2017 A$4.11 M-26.35%
2016 A$5.58 M28.84%
2015 A$4.33 M-14.03%
2014 A$5.04 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Enzo Biochem
ENZB
A$41.36 M 428.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A$0.10 B 1,263.78%๐Ÿ‡บ๐Ÿ‡ธ USA